Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.145 -0.235 (-3.68%) Market Cap: 941.56 Mil Enterprise Value: 838.75 Mil PE Ratio: 0 PB Ratio: 4.20 GF Score: 81/100

Q2 2022 Adaptive Biotechnologies Corp Earnings Call Transcript

Aug 03, 2022 / 08:30PM GMT
Release Date Price: $9.89 (+3.89%)
Operator

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Karina Calzadilla, Head of Investor Relations. Please go ahead.

Karina Calzadilla
Adaptive Biotechnologies Corporation - VP of IR

Thank you, Daniel. Thank you, Daniel, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies Second Quarter 2022 Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive financial results for the second quarter of 2022. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call, and we'll be referencing to a slide presentation that has been posted to the Investors section in our corporate website.

During the call, management will make projections and other forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot